XML 16 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
3 Months Ended
Aug. 03, 2013
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
5.            Stock-Based Compensation

The compensation costs that have been charged against income for the thirteen and twenty-six weeks ended August 3, 2013 and July 28, 2012 were as follows (in thousands):
 
 
Thirteen Weeks Ended
  
Twenty-Six Weeks Ended
 
 
August 3, 2013
  
July 28, 2012
  
August 3, 2013
  
July 28, 2012
 
Stock-based compensation expense by type:
        
  Stock options
 
$
14
  
$
33
  
$
323
  
$
742
 
  Restricted stock unit awards, including performance-based
  
899
   
1,065
   
2,885
   
2,954
 
  Employee stock purchase
  
17
   
17
   
59
   
35
 
  Director deferred compensation
  
32
   
6
   
62
   
6
 
    Total stock-based compensation expense
  
962
   
1,121
   
3,329
   
3,737
 
Income tax benefit recognized
  
353
   
416
   
1,229
   
1,393
 
      Stock-based compensation expense, net of income tax
 
$
609
  
$
705
  
$
2,100
  
$
2,344
 
 
In the thirteen and twenty-six weeks ended August 3, 2013 and July 28, 2012, we granted the following equity awards:
 
 
Thirteen Weeks Ended
  
Twenty-Six Weeks Ended
 
 
August 3, 2013
  
July 28,
 2012
  
August 3, 2013
  
July 28,
2012
 
Stock options
  
818
   
1,576
   
18,441
   
38,242
 
Restricted stock unit awards
  
--
   
--
   
62,625
   
63,516
 
Performance-based restricted stock unit awards
  
--
   
--
   
36,700
   
38,100
 
Deferred stock units
  
578
   
109
   
7,475
   
109
 
 
Under the 2012 Non-Employee Director Equity Plan (2012 Plan), a total of 2,312 shares of our common stock were awarded during the twenty-six weeks ended August 3, 2013 as part of the annual equity award to directors in the first quarter.  Prior to the adoption of the 2012 Plan, the annual equity award to directors was solely in stock options.  In addition, under our employee stock purchase plan, our employees purchased 1,385 and 4,866 shares of our common stock during the thirteen and twenty-six weeks ended August 3, 2013, respectively and 1,317 and 4,414 shares of our common stock during the thirteen and twenty-six weeks ended July 28, 2012, respectively.
 


The weighted-average grant date fair value of stock options granted during the thirteen and twenty-six weeks ended August 3, 2013 was $17.40 and $17.52 per share, respectively.  The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $12.23 and $12.09, respectively, and the weighted-average price paid by our employees for shares of our common stock was $47.18 and $44.80, respectively, during the thirteen and twenty-six weeks ended August 3, 2013.

The weighted-average grant date fair value of stock options granted during the thirteen and twenty-six weeks ended July 28, 2012 was $21.24 and $19.40 per share, respectively.  The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $12.75 and $7.78, respectively, and the weighted-average price paid by our employees for shares of our common stock was $46.37 and $40.78, respectively, during the thirteen and twenty-six weeks ended July 28, 2012.

At August 3, 2013, the total compensation costs, related to nonvested restricted stock unit awards not yet recognized was $11.4 million and the weighted-average period over which such awards are expected to be recognized was 2.8 years.  There are no future compensation costs related to nonvested stock options to be recognized at August 3, 2013.